Novantrone

Known as: Novantron, Ralenova 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
Multiple sclerosis (MS) is a chronic inflammatory autoimmune demyelinating disease of the central nervous system. It affects… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
2009
2009
Some familial neurodegenerative diseases are associated with mutations that destabilize a putative stem-loop structure within an… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
Review
2004
Review
2004
The conclusions of a recent study of mitoxantrone (Novantrone) in multiple sclerosis and the approval of several health… (More)
Is this relevant?
Review
2003
Review
2003
Mitoxantrone is the first drug approved for the treatment of secondary progressive multiple sclerosis (SPMS) in the United States… (More)
Is this relevant?
2002
2002
BACKGROUND AND OBJECTIVES The objective of improving the quality of responses of chronic lymphocytic leukemia (CLL) patients has… (More)
Is this relevant?
1998
1998
Due to the close homology between bacterial and tumor cell transporter proteins, some antiplasmid and anticancer compounds were… (More)
Is this relevant?
1997
1997
CONCLUSION Celiac artery infusion (CAI) seems to be a qualified and successful method for adjuvant treatment of pancreatic cancer… (More)
Is this relevant?
1991
1991
Caffeine is known to potentiate the cytotoxicity of a variety of DNA damaging agents presumably by reducing the ability of the… (More)
Is this relevant?
1991
1991
Exposure of L1210 cells to DNA-intercalating antitumor drugs Novantrone (mitoxantrone; 20 ng/ml), doxorubicin (0.5 micrograms/ml… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
1983
1983
Nineteen out of 62 evaluable patients with advanced breast cancer achieved an objective tumour response to mitoxantrone (31… (More)
Is this relevant?